By: Sarah O'Brien
Depending on their Medicare coverage, beneficiaries could save between $2 and $390 per average dose for these drugs starting April 1, officials announced.
Sarah O'Brien is a reporter who has written for various publications including CNBC, Lexology, The University of Melbourne, and The American Lawyer. Her articles cover a wide range of topics including healthcare, finance, legal issues, and technology. Sarah's work has also been featured in NBC affiliates and other media outlets.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Sarah O’Brien's focus is primarily on finance, with a significant portion of her coverage addressing legal policy regulations and government announcements. She also covers health-related topics such as Medicare and financial planning.
Given Sarah’s emphasis on citing data and government announcements in the context of business law, data protection, cybersecurity, Medicare, and financial planning, she would likely be receptive to pitches providing expert commentary or analysis related to recent regulatory changes or data-backed insights in these areas.
Considering that Sarah does not have a specific geographic focus but operates within the United States, it would be beneficial for potential sources to provide information relevant to U.S. regulations or impacts.
This information evolves through artificial intelligence and human feedback. Improve this profile .